Exploring Novel Ibrutinib Combinations in Clinical Trials for CLL
January 16th 2020Jennifer A. Woymach, MD, provides background information on the AO41702 study, which evaluates targeted therapy ibrutinib or ibrutinib plus rituximab in elderly patients with previously untreated chronic lymphocytic leukemia.<br />